Goldman Sachs initiates Teva, Viatris, and Amneal, highlighting branded growth and pipeline strength, but one company's ...

Fintel reports that on June 6, 2025, Goldman Sachs upgraded their outlook for MasTec (NYSE:MTZ) from Neutral to Buy. Analyst ...

Fintel reports that on June 6, 2025, Goldman Sachs downgraded their outlook for MYR Group (NasdaqGS:MYRG) from Buy to Neutral ...

Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral ...

Teva Pharmaceutical (TEVA) stock, Amneal Pharma (AMRX) stock receive Buy ratings and Viatris (VTRS) stock receives a Neutral rating at Goldman Sachs. Read more here.

Elon Musk has alienated “multiple sides of the political spectrum” from Tesla, according to one prominent Wall Street analyst ...

Blackstone ’s nontraded REIT has refinanced a 59-property industrial portfolio across 13 states. It secured a $1B CMBS loan ...

Gold price today are getting influenced by global economic uncertainties, geo-politics, financial unrest, US government ...

In May, job gains were especially strong in the health care, leisure and hospitality, and social assistance sectors. However ...

According to analysts at Goldman Sachs , it's the central banks acting as a driving purchasing force behind the current ...

Asset managers in Brazil are ramping up to take full advantage of a comeback in local equities after long stretches of weak ...

These four familiar stocks are perfect ideas for growth and income investors seeking reliable dividends, passive income, and ...